Clicky

Mabion S.A.(MAB)

Description: Mabion S.A., a biotechnology company, engages in the development of various biotech drugs based on monoclonal antibody technology in Poland. The company develops, produces, and sells medicines for the treatment of neoplastic, autoimmune, metabolic, and neurological diseases. Its products include MabionCD20 and MabionHER2. The company was founded in 2007 and is based in Konstantynów Lódzki, Poland.


Keywords: Medicine Biotechnology Life Sciences Medication Monoclonal Antibody Neurological Diseases Immunocore Janssen Biotech

Home Page: www.mabion.eu

ul. gen. Mariana Langiewicza 60
Konstantynów Lódzki, 95-050
Poland
Phone: 48 42 207 7890


Officers

Name Title
Mr. Krzysztof Kaczmarczyk CEO & Pres of Management Board
Dr. Slawomir Jaros EMBA, Eng., Ph.D. Member of the Management Board & Scientific Director
Mr. Grzegorz Grabowicz Member of Management Board
Mr. Adam Pietruszkiewicz Member of the Management Board
Katarzyna Alicja Kutera-Wasiak Chief Accountant

Exchange: WAR

Country: PL : Poland

Currency: Polish złoty (zł)

Forward PE: 0
Trailing PE: 8.191
Price-to-Book MRQ: 6.2455
Price-to-Sales TTM: 2.2813
IPO Date:
Fiscal Year End: December
Full Time Employees: 244
Back to stocks